Tagged MannKind Corporation

MannKind Corporation

Sanofi and Mannkind launches FDA approved inhalable Insulin Afrezza for diabetics in the US

Feb 3, 2015

Approved by the U.S. Food and Drugs Administration (FDA) in June, Sanofi has on Tuesday launched the only inhalable insulin product for type 1 and type 2 diabetics in the US. The medication was developed by Man...

FDA approves new inhaled insulin Afrezza

Jun 28, 2014

FDA - The U.S. Food and Drug Administration approved a new form of insulin that can be inhaled rather than injected. Called Afrezza, the drug is a dry powder that diabetes patients can breathe in using an insul...